0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Oncology | 
Invited Commentary |  FREE ONLINE FIRST
Charles D. Blanke, MD; Erik K. Fromme, MD
JAMA Oncol. Published online July 23, 2015. doi:10.1001/jamaoncol.2015.2379

JAMA Oncology | 
Invited Commentary |  ONLINE FIRST
Heikki Joensuu, MD
JAMA Oncol. Published online July 23, 2015. doi:10.1001/jamaoncol.2015.2404

JAMA Oncology | 
Original Investigation |  FREE ONLINE FIRST
Holly G. Prigerson, PhD; Yuhua Bao, PhD; Manish A. Shah, MD; et al.
JAMA Oncol. Published online July 23, 2015. doi:10.1001/jamaoncol.2015.2378

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Annie Guérin, MSc; Medha Sasane, PhD; Christopher Hunt Keir, MD; et al.
JAMA Oncol. Published online July 23, 2015. doi:10.1001/jamaoncol.2015.2407
Includes: Supplemental Content

JAMA Oncology | 
Review |  ONLINE FIRST
Mark M. Moasser, MD; Ian E. Krop, MD, PhD
JAMA Oncol. Published online July 23, 2015. doi:10.1001/jamaoncol.2015.2286

JAMA Dermatology | 
Research Letter |  ONLINE FIRST
Mina S. Ally, MD; Jean Y. Tang, MD, PhD; Joselyn Lindgren, MS; et al.
JAMA Dermatol. Published online July 22, 2015. doi:10.1001/jamadermatol.2015.1937

JAMA Oncology | 
Viewpoint |  FREE ONLINE FIRST
Laura E. MacConaill, PhD; Neal I. Lindeman, MD; Barrett J. Rollins, MD, PhD
JAMA Oncol. Published online July 16, 2015. doi:10.1001/jamaoncol.2015.1540

JAMA Oncology | 
Brief Report |  ONLINE FIRST
Brooke E. Howitt, MD; Sachet A. Shukla, PhD; Lynette M. Sholl, MD; et al.
JAMA Oncol. Published online July 09, 2015. doi:10.1001/jamaoncol.2015.2151
Includes: Supplemental Content

JAMA Oncology | 
Editor's Note |  FREE ONLINE FIRST
Charles R. Thomas Jr, MD
JAMA Oncol. Published online July 09, 2015. doi:10.1001/jamaoncol.2015.2197

JAMA Oncology | 
Research Letter |  ONLINE FIRST
Yongli Ji, MD; Joanna Schwartz, RPh; Alan Hartford, MD, PhD; et al.
JAMA Oncol. Published online July 09, 2015. doi:10.1001/jamaoncol.2015.1300

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Invited Commentary  | 
Chemotherapy Near the End of Life: First—and Third and Fourth (Line)—Do No Harm
Charles D. Blanke, MD; Erik K. Fromme, MD
JAMA Oncology
Invited Commentary  | 
Physician Estimations of the Risk of Gastrointestinal Stromal Tumor Recurrence—Not Accurate Enough? More Education May Be Needed
Heikki Joensuu, MD
JAMA Oncology
Original Investigation  | 
Chemotherapy Use, Performance Status, and Quality of Life at the End of Life
Holly G. Prigerson, PhD; Yuhua Bao, PhD; Manish A. Shah, MD; et al.
JAMA Oncology
Original Investigation  | 
Physician Underestimation of the Risk of Gastrointestinal Stromal Tumor Recurrence After Resection
Annie Guérin, MSc; Medha Sasane, PhD; Christopher Hunt Keir, MD; et al.